DDAH2 mRNA expression is inversely associated with some cardiovascular risk-related features in healthy young adults

Disease Markers

Volumn 27, Issue 1, 2009, Pages 37-44

  Puchau, Blanca ^a   Hermsdorff, Helen Hermana M ^a   Zulet, M Ángeles ^a   Martínez, J Alfredo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Asymmetric dimethylarginine (ADMA); Atherosclerosis; Cardiovascular risk; Dimethylarginine dimethylaminohydrolase 2 (DDAH2); Nitric oxide synthase 3 (NOS3); Protein arginine N methyltransferase type I 1 (PRMT1)

Indexed keywords

DIMETHYLARGININASE; DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE N METHYLTRANSFERASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

EID: 70350497592     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2009-0650     Document Type: Article

References (45)

1. P. Brenneisen, H. Steinbrenner and H. Sies, Selenium, oxidative stress, and health aspects, Mol Aspects Med 26 (2005), 256-267.
2. T. Fulop, D. Tessier and A. Carpentier, The metabolic syndrome, Pathol Biol (Paris) 54 (2006), 375-386.
3. P. Dandona, A. Aljada and A. Bandyopadhyay, Inflammation: the link between insulin resistance, obesity and diabetes, Trends Immunol 25 (2004), 4-7.
4. P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty and R. Garg, Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation, Circulation 111 (2005), 1448-1454.
5. M.J. Moreno-Aliaga, J. Campíon, F.I. Milagro, A. Berj́on and J.A. Martinez, Adiposity and proinflammatory state: the chicken or the egg, Adipocytes 1 (2005), 1-16.
6. P. Trayhurn and I.S.Wood, Adipokines: inflammation and the pleiotropic role of white adipose tissue, Br J Nutr 92 (2004), 347-355.
7. C. Zoccali, F. Mallamaci and G. Tripepi, Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease, Kidney Int Suppl (2003), S65-S68.
8. L.F. Van Gaal, I.L. Mertens and C.E. De Block, Mechanisms linking obesity with cardiovascular disease, Nature 444 (2006), 875-880.
9. S.A. Ritchie, M.A. Ewart, C.G. Perry, J.M. Connell and I.P. Salt, The role of insulin and the adipocytokines in regulation of vascular endothelial function, Clin Sci (Lond) 107 (2004), 519-532.
10. H. Ghanim, A. Aljada, D. Hofmeyer, T. Syed, P. Mohanty and P. Dandona, Circulating mononuclear cells in the obese are in a proinflammatory state, Circulation 110 (2004), 1564-1571.
11. E. Goyenechea, D. Parra, A.B. Crujeiras, I. Abete and J.A. Martinez, A nutrigenomic inflammation-related PBMC-based approach to predict the weight-loss regain in obese subjects, Ann Nutr Metab 54 (2009), 43-51.
12. N. Viguerie, H. Vidal, P. Arner, C. Holst, C. Verdich, S. Avizou, A. Astrup, W.H. Saris, I.A. Macdonald, E. Klimcakova, K. Clement, A. Martinez, J. Hoffstedt, T.I. Sorensen and D. Langin, Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets, Diabetologia 48 (2005), 123-131. (Pubitemid 40174664)
13. R.H. Boger, The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor, Cardiovasc Res 59 (2003), 824-833.
14. J.P. Cooke, Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20 (2000), 2032-2037.
15. B. Spoto, R.M. Parlongo, G. Parlongo, E. Sgro and C. Zoccali, The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes, J Nephrol 20 (2007), 554-559.
16. S. Clarke, Protein methylation, Curr Opin Cell Biol 5 (1993), 977-983.
17. N. Rawal, R. Rajpurohit, M.A. Lischwe, K.R. Williams, W.K. Paik and S. Kim, Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltransferases, Biochim Biophys Acta 1248 (1995), 11-18.
18. M. Kimoto, G.S. Whitley, H. Tsuji and T. Ogawa, Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody, J Biochem 117 (1995), 237-238.
19. T. Ogawa, M. Kimoto and K. Sasaoka, Occurrence of a new enzyme catalyzing the direct conversion of NG,NG-dimethyl- L-arginine to L-citrulline in rats, Biochem Biophys Res Commun 148 (1987), 671-677.
20. R.S. Gibson, Principles of Nutritional Assessment, Oxford University Press, New York, 2005.
21. J. Warnberg, E. Nova, L.A. Moreno, J. Romeo, M.I. Mesana, J.R. Ruiz, F.B. Ortega, M. Sjostrom, M. Bueno and A. Marcos, Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study, Am J Clin Nutr 84 (2006), 505-512.
22. W.T. Friedewald, R.I. Levy and D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem 18 (1972), 499-502.
23. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher and R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting glucose and insulin concentrations in men, Diabetologia 28 (1985), 412-419.
24. K.J. Livak and T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)), Method Methods 25 (2001), 402-408.
25. F.I. Milagro, J. Campion and J.A. Martinez, 11-Beta hydroxysteroid dehydrogenase type 2 expression in white adipose tissue is strongly correlated with adiposity, J Steroid Biochem Mol Biol 104 (2007), 81-84.
26. B. Puchau, M.A. Zulet, G. Urtiaga, I. Navarro-Blasco and J.A. Martinez, ADMA regulation by antioxidants intake in healthy young adults: a role as an early indicator of metabolic syndrome features, Metabolism (2009), DOI:10.1016/j.metabol.2009.04.037.
27. E.B. Marliss, S. Chevalier, R. Gougeon, J.A. Morais, M. Lamarche, O. A. Adegoke and G. Wu, Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover, Diabetologia 49 (2006), 351-359.
28. S. Debey, T. Zander, B. Brors, A. Popov, R. Eils and J.L. Schultze, A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials, Genomics 87 (2006), 653-664.
29. H.M. Eid, H. Arnesen, E.M. Hjerkinn, T. Lyberg and I. Selje- flot, Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, Metabolism 53 (2004), 1574-1579.
30. K. Krzyzanowska, F. Mittermayer, H.P. Kopp, M. Wolzt and G. Schernthaner,Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women, J Clin Endocrinol Metab 89 (2004), 6277-6281.
31. A. Onat, G. Hergenc, G. Can and A. Karabulut, Serum asymmetric dimethylarginine levels among Turks: association with metabolic syndrome in women and tendency to decrease in smokers, Turk Kardiyol Dern Ars 36 (2008), 7-13.
32. J.T. Kielstein and P.S. Tsao, From Zanius to ADMA:ADMA- a new "adipocytokine" and its potential role in metabolic syndrome, J Nephrol 20 (2007), 515-517.
33. K. Andersson, N. Gaudiot, C. Ribiere, M. Elizalde, Y. Giudicelli and P. Arner, A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo, Br J Pharmacol 126 (1999), 1639-1645.
34. J. Niebauer, A.L. Clark, K.M.Webb-Peploe, R. Boger and A.J. Coats, Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure, Eur J Heart Fail 7 (2005), 183-188.
35. D. Wang, P.S. Gill, T. Chabrashvili, M.L. Onozato, J. Raggio, M. Mendonca, K. Dennehy, M. Li, P. Modlinger, J. Leiper, P. Vallance, O. Adler, A. Leone, A. Tojo, W.J. Welch and C.S. Wilcox, Isoform-specific regulation by N(G),N(G)- dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing relaxing factor/NO, Circ Res 101 (2007), 627-635.
36. H. Miyazaki, H. Matsuoka, J.P. Cooke, M. Usui, S. Ueda, S. Okuda and T. Imaizumi, Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis, Circulation 99 (1999), 1141-1146. (Pubitemid 29120084)
37. M.I. Yilmaz, M. Saglam, K. Caglar, E. Cakir, A. Sonmez, T. Ozgurtas, A. Aydin, T. Eyileten, O. Ozcan, C. Acikel, M. Tasar, G. Genctoy, K. Erbil, A. Vural and C. Zoccali, The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine, Am J Kidney Dis 47 (2006), 42-50.
38. D. Konukoglu, S. Firtina and O. Serin, The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance, Metabolism 57 (2008), 110-115.
39. G.G. Zhang, Y.P. Bai, M.F. Chen, R.Z. Shi, D.J. Jiang, Q.M. Fu, G.S. Tan and Y.J. Li, Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C, Vascul Pharmacol 48 (2008), 115-121.
40. A. Fard, C.H. Tuck, J.A. Donis, R. Sciacca, M.R. Di Tullio, H. D. Wu, T. A. Bryant, N. T. Chen, M. Torres-Tamayo, R. Ramasamy, L. Berglund, H. N. Ginsberg, S. Homma and P. J. Cannon, Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes, Arterioscler Thromb Vasc Biol 20 (2000), 2039-2044.
41. V.P.Valkonen, H. Paiva, J.T. Salonen, T.A. Lakka, T. Lehtimaki, J. Laakso and R. Laaksonen, Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine, Lancet 358 (2001), 2127-2128.
42. A. Ito, P.S. Tsao, S. Adimoolam, M. Kimoto, T. Ogawa and J.P. Cooke, Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase, Circulation 99 (1999), 3092-3095.
43. C.T. Tran, J.M. Leiper and P. Vallance, The DDAH/ADMA/ NOS pathway, Atheroscler Suppl 4 (2003), 33-40.
44. C.D. Krause, Z.H. Yang, Y.S. Kim, J.H. Lee, J.R. Cook and S. Pestka, Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential, Pharmacol Ther 113 (2007), 50-87.
45. C.W. Lu, Y. Xiong and P. He, Dimethylarginine dimethylaminohydrolase- 2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein, Nitric Oxide 16 (2007), 94-103.